- John McMurray
- Department of Cardiology, Western General Hospital, Edinburgh EH4 2XU, consultant.
- University Department of Medical Cardiology, Royal Infirmary, Glasgow G31 2ER, senior lecturer.
- Correspondence to: Dr McMurray.
- Andrew Rankin
- Department of Cardiology, Western General Hospital, Edinburgh EH4 2XU, consultant.
- University Department of Medical Cardiology, Royal Infirmary, Glasgow G31 2ER, senior lecturer.
In the first part of our review of the advances in cardiology over the past year we considered treatment of myocardial infarction and angina.1 In this part we summarise the most important advances in the treatment of heart failure, atrial fibrillation, and arrhythmias. A glossary of study abbreviations is given in the appendix.
Heart failure and digoxin
In the past year, more has been learnt about what does not help patients with chronic heart failure than what is of benefit. Important American guidelines on treatment have also been issued.2
Two trials have investigated whether digoxin is of benefit in patients with chronic heart failure who are in sinus rhythm.3 4 In both trials the condition was stabilised by digoxin treatment before patients were randomly allocated in a double blind fashion to withdrawal (placebo substitution) or continuation of digoxin. In one study (PROVED) patients were not treated with an angiotensin converting enzyme inhibitor whereas in the other (RADIANCE) they were. During follow up of three months the patients in both groups who had had digoxin withdrawn showed clinical deterioration (table I).
- In this window
- In a new window
Outcomes after three months in trials of digoxin withdrawal in patients with chronic heart failure3–4
The results of these trials are important advances in our understanding of the role of digoxin in chronic heart failure. For patients who remain symptomatic while taking a diuretic but cannot tolerate an angiotensin converting enzyme inhibitor, digoxin is an option. Similarly, patients who remain symptomatic despite taking an angiotensin converting enzyme inhibitor should also be treated with digoxin.
The one caveat to these conclusions is whether deterioration after digoxin withdrawal (as seen in the studies) is the same as clinical improvement when the drug is added to existing drug treatment. Other studies suggest that the addition of digoxin to diuretics is of …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012